Photodynamic therapy: a distinct therapeutic modality
Main Article Content
Abstract
Photodynamic therapy (PDT) is an innovative treatment modality that utilizes a combination of a photosensitizing agent, specific wavelengths of light, and molecular oxygen to selectively target and destroy abnormal cells or tissues while sparing healthy surrounding structures. This approach has gained significant attention in the medical field due to its potential to provide effective and less invasive treatment options for various conditions. The development of PDT was driven by the need for treatments that overcome the limitations of conventional modalities such as surgery, radiation therapy, and chemotherapy. PDT offers several benefits over these approaches, including its ability to provide targeted therapy, reduced side effects, minimal damage to healthy tissues, and versatility in treating different diseases. One of the key advantages of PDT is its selectivity. By utilizing photosensitizers that accumulate in diseased or abnormal cells, PDT can precisely target the affected tissue while minimizing damage to healthy tissues. This selectivity allows for focused treatment, reducing the potential for unnecessary harm to surrounding structures. Furthermore, PDT offers faster recovery times and potentially better cosmetic outcomes compared to surgery, as it does not require extensive incisions or removal of tissues. Additionally, the localized nature of PDT minimizes systemic toxicity and long-term complications, making it a well-tolerated treatment option. PDT has demonstrated efficacy in various medical fields, including oncology, dermatology, and ophthalmology. It has been used to treat different types of cancers, including skin, lung, oesophagal, and bladder cancer, as well as manage conditions like age-related macular degeneration and certain dermatological disorders. This article reviewed the development, mechanism, and applications of PDT in the medical field.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
- Allison RR, Moghissi K. Photodynamic Therapy (PDT): PDT Mechanisms. Clin Endosc. 2013;46(1):24-29. http://dx.doi.org/10.5946/ce.2013.46.1.24
- Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3(5):380-387. http://dx.doi.org/10.1038/nrc1071
- Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 2000;1:212-219. http://dx.doi.org/10.1016/S1470-2045(00)00190-3
- Huang Z. A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat. 2005;4(3):283-293. http://dx.doi.org/10.1177/153303460500400308
- Dougherty TJ. Photodynamic therapy: Origins, early success, and new horizons. J Natl Cancer Inst. 1998;90(12):889-905. http://dx.doi.org/10.1093/jnci/90.12.889
- Celli JP, Spring BQ, Rizvi I, et al. Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization. Chem Rev. 2010;110(5):2795-2838. http://dx.doi.org/10.1021/cr900300p
- Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5(8):497-508. http://dx.doi.org/10.1016/S1470-2045(04)01529-3
- Hopper C, Niziol C. Photodynamic therapy in head and neck cancer: 14 years' experience. Lasers Surg Med. 2006;38(5):349-355. http://dx.doi.org/10.1002/lsm.20275
- Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: An update. CA Cancer J Clin. 2011;61(4):250-281. http://dx.doi.org/10.3322/caac.20114
- Dougherty TJ. Photosensitizers: Therapy and Detection of Malignant Tumours. Photochem Photobiol. 1987;45(6):879-889. http://dx.doi.org/10.1111/j.1751-1097.1987.tb08435.x
- Babilas P, Schreml S, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology: state-of-the-art. Photodermatol Photoimmunol Photomed. 2010;26(3):118-132. http://dx.doi.org/10.1111/j.1600-0781.2010.00537.x
- Pandey RK, Dougherty TJ. Hematoporphyrin derivative (HPD)-mediated photosensitization. II. Normal tissue distribution and photosensitizing efficiency of tumour-localizing porphyrins. J Natl Cancer Inst. 1984;73(2):347-352. http://dx.doi.org/10.1093/jnci/73.2.347
- Henderson BW, Dougherty TJ. How does Photodynamic Therapy Work?. Photochem Photobiol. 1992;55(1):145-157. http://dx.doi.org/10.1111/j.1751-1097.1992.tb04227.x
- Allison RR, Sibata CH. Oncologic photodynamic therapy photosensitizers: a clinical review. Photodiagnosis Photodyn Ther. 2010;7(2):61-75. http://dx.doi.org/10.1016/j.pdpdt.2010.02.004
- Shah JP, Lydiatt W. Treatment of Cancer. In: Flint PW, Haughey BH, Lund VJ, et al., eds. Cummings Otolaryngology - Head and Neck Surgery. 6th ed. Elsevier Saunders; 2015:2029-2061.
- Halperin EC, Brady LW, Perez CA, Wazer DE, eds. Perez & Brady's Principles and Practice of Radiation Oncology. 6th ed. Lippincott Williams & Wilkins; 2013.
- Chabner BA, Roberts TG Jr. Chemotherapy and the War on Cancer. Nat Rev Cancer. 2005;5(1):65-72. http://dx.doi.org/10.1038/nrc1529
- Samia N, Hassan H, Khaled HM. Photodynamic therapy in cancer: A concise review. J Cancer Res Ther. 2019;15(4):799-804. http://dx.doi.org/10.4103/jcrt.JCRT_559_18
- Juarranz Á, Jaén P, Sanz-Rodríguez F, Cuevas Santos J, González S. Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol. 2008;10(3):148-154. http://dx.doi.org/10.1007/s12094-008-0184-3
- Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3(5):380-387. http://dx.doi.org/10.1038/nrc1071
- Huggett MT, Jermyn M, Gillams A, et al. Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. Br J Cancer. 2014;110(7):1698-1704. http://dx.doi.org/10.1038/bjc.2014.85
- Cengel KA, Glatstein E. Photodynamic therapy: A clinical update. J Natl Compr Canc Netw. 2010;8(12):1457-1466. http://dx.doi.org/10.6004/jnccn.2010.0102
- Mallidi S, Anbil S, Bulin AL, et al. Beyond the barriers of light penetration: Strategies, perspectives and possibilities for photodynamic therapy. Theranostics. 2016;6(13):2458-2487. http://dx.doi.org/10.7150/thno.16178
- Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 2000;1:212-219. http://dx.doi.org/10.1016/S1470-2045(00)00190-3
- Chen B, Pogue BW, Hoopes PJ, Hasan T. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Int J Radiat Oncol Biol Phys. 2005;61(4):1216-1226. http://dx.doi.org/10.1016/j.ijrobp.2004.11.006
- Lorusso L, Ciliberti MP, Solima E, et al. Photodynamic therapy of recurrent head and neck cancer: a case series of 23 patients. Photodiagnosis Photodyn Ther. 2017;20:13-19. http://dx.doi.org/10.1016/j.pdpdt.2017.08.008
- Allison RR, Moghissi K. Photodynamic Therapy (PDT): PDT Mechanisms. Clin Endosc. 2013;46(1):24-29. http://dx.doi.org/10.5946/ce.2013.46.1.24.
- Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000;42(3):389-413.
- Luksiene Z. Photodynamic therapy: mechanism of action and ways to improve the efficiency of treatment. Medicina (Kaunas, Lithuania). 2003 Jan 1;39(12):1137-50.
- Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ. Photodynamic therapy in oncology. Expert Opin Pharmacother 2001; 2:1-11.
- Oleinick NL, Morris RL, Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci. 2002;1(1):1-21. http://dx.doi.org/10.1039/B108586G
- Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications—actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol. 2008;22(5):579-593. http://dx.doi.org/10.1111/j.1468-3083.2008.02671.x
- Morton C A, McKenna KE, Rhodes LE, British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for topical photodynamic therapy: update. Brit J Dermatol. 2008;159(6), 1245-1266. http://dx.doi.org/10.1111/j.1365-2133.2008.08869.x
- Morton CA, Szeimies RM, Sidoroff A, et al. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications – actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol. 2013;27(5):536-544. http://dx.doi.org/10.1111/j.1468-3083.2012.04595.x
- Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007;56(1):125-143. http://dx.doi.org/10.1016/j.jaad.2006.05.045
- Moghissi K, Dixon K. Photodynamic therapy (PDT) in lung cancer: a systematic review. Med Laser Appl. 2015;30(2):61-69. http://dx.doi.org/10.1016/j.mla.2015.03.004
- Moghissi K, Dixon K. Photodynamic therapy (PDT) in early central lung cancer (ECLC). Photodiagnosis and Photodynamic Therapy. 2016;14:216-221. http://dx.doi.org/10.1016/j.pdpdt.2016.02.004
- Chhatre S, Vachani A, Allison RR, Jayadevappa R. Survival outcomes with photodynamic therapy, chemotherapy and radiation in patients with stage III or stage IV non-small cell lung cancer. Cancers. 2021 Feb 15;13(4):803.
- Crous A, Abrahamse H. Photodynamic therapy of lung cancer, where are we? Front Pharmacol. 2022 Aug 30;13:932098. http://dx.doi.org/10.3389/fphar.2022.932098.
- Wang W, Luo Y, Wang Y, Wang H, Zhou X, Wang, J, et al. Photodynamic therapy for esophageal cancer: a systematic review and meta-analysis. Dis Esophagus. 2015; 28(8):723-735. http://dx.doi.org/10.1111/dote.12262
- Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 2006;7(10):813-822.
- Wang S, Huang Z, Huang P, Hamblin MR. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part I. Acne vulgaris: when and why consider photodynamic therapy? J Am Acad Dermatol. 2017;76(4):639-655. http://dx.doi.org/10.1016/j.jaad.2016.11.040
- Photodynamic Therapy: New Approaches in Dermatology. In: Gold M., Nestor M., editors. Therapeutic Uses of Botulinum Toxin. Springer, Cham. 2018. http://dx.doi.org/10.1007/978-3-319-65826-9_15
- Morton CA, Scholefield RD, Whitehurst C, Birch J. An open study to determine the efficacy of blue light in the treatment of mild to moderate acne. J Dermatolog Treat. 2005;16(4):219-223. http://dx.doi.org/10.1080/09546630500293963
- Gold MH, Bradshaw VL, Boring MM. The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory acne vulgaris. J Drugs Dermatol. 2009;8(9):836-841.
- Morton CA, Szeimies RM. Actinic keratosis and other precursors to squamous cell carcinoma. In Evidence-Based Dermatology. BMJ Books. 2005. Pp. 274-287. http://dx.doi.org/10.1002/9780470988354.ch18
- Rendon MI, Berson DS, Cohen JL, Roberts W E. Evidence and considerations in the application of photodynamic therapy in acne vulgaris: An update. J Drugs Dermatol. 2006;5(1): 78-84.
- Morton CA, Campbell SM, Whitehurst C. Treatment of psoriasis with topical aminolaevulinic acid photodynamic therapy: a pilot study. Brit J Dermatol. 2000;143(5):965-968. http://dx.doi.org/10.1046/j.1365
- van Dijk EHC, van Rijssen TJ, Subhi Y, Boon CJF. Photodynamic Therapy for Chorioretinal Diseases: A Practical Approach. Ophthalmol Ther. 2020 Jun;9(2):329-342. http://dx.doi.org/10.1007/s40123-020-00250-0
- Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials—TAP Report 1. Arch Ophthalmol. 1999;117(10):1329-1345.
- Verteporfin In Photodynamic Therapy (VIP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—Verteporfin In Photodynamic Therapy Report 2. Am J Ophthalmol. 2002; 131(5): 541-560.
- Verteporfin In Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial—VIP report no. 1. Ophthalmol. 2002;109(10):1751-1766.
- Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 3-year results of a randomized clinical trial—TAP report no. 5. Ophthalmol. 2004;111(9):1575-1580.
- Huang D, Jager MJ, Jockovich E. Retinal photodynamic therapy: current concepts and new developments. Intraocular Tumours: An Atlas and Textbook, 2012; pp. 65-72. Springer, Heidelberg. http://dx.doi.org/10.1007/978-3-642-28890-3_9
- Basaran Y, Al-Muammar A, Khoury M, Tabbara KF. Photodynamic therapy for the treatment of ocular surface squamous neoplasia: a systematic review. Ocul Oncol Pathol. 2020;6(2):81-88. http://dx.doi.org/10.1159/000504560
- Hamblin MR, Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci. 2004;3(5):436-450. http://dx.doi.org/10.1039/B311900A
- Wilson M. Photodynamic therapy for the treatment of oral and periodontal infections. Photodiagnosis Photodyn Ther. 2004;1(1): 27-43. http://dx.doi.org/10.1016/S1572-1000(04)00007-5
- Maisch T. Resistance in antimicrobial photodynamic inactivation of bacteria. Photochem Photobiol Sci.. 2015:14(8):1518-1526. http://dx.doi.org/10.1039/C4PP90035A
- Fuchs BB, Mylonakis E. Using non-mammalian hosts to study fungal virulence and host defense. Curr Opin Microbiol. 2006;9(4):346-351. http://dx.doi.org/10.1016/j.mib.2006.06.007
- Tavares A, Carvalho CM, Faustino MA, Neves MG, Tomé JP, Tomé AC, et al. Antifungal photodynamic therapy: challenges to fight against fungal infections. Journal of Photochem Photobiol Sci. B: Biology. 2010;101(1):90-98. http://dx.doi.org/10.1016/j.jphotobiol.2010.05.008
- Soukos NS, Goodson JM, Photodynamic Therapy in Dentistry. Photodynamic therapy in the control of oral biofilms. Periodontol 2000. 2009;51(1):140-150. http://dx.doi.org/10.1111/j.1600-0757.2009.00328.x
- Ribeiro FS, Pires L, De Souza GL, Pereira TS, Zanin FA, Brugnera Jr. A. Photodynamic therapy as an adjunctive treatment for chronic periodontitis: a systematic review and meta-analysis. Lasers Med Sci 2017:32(4):953-965. http://dx.doi.org/10.1007/s10103-017-2190-5
- Fimple JL, Fontana CR, Foschi F, Ruggiero K, Song X, Pagonis TC, et al. Photodynamic treatment of endodontic polymicrobial infection in vitro. J Endod. 2008:34(6):728-734. http://dx.doi.org/10.1016/j.joen.2008.02.032
- Meire MA, Coenye T, Nelis HJ, De Moor RJ, Meire MA. Effectiveness of antimicrobial photodynamic therapy on the disinfection of rough titanium surfaces in the presence of oral biofilms. Clin Oral Implants Res. 2017;28(8):957-963. http://dx.doi.org/10.1111/clr.12902
- Chen HM, Yu CH, Chen CT, Chang YC, Chiang CP, Wu YC, et al. Photodynamic therapy for the treatment of oral leukoplakia and oral erythroplakia: a case series and review of the literature. J Formos Med Assoc. 2011;110(4): 239-245.
- Mohammadi Z, Shalavi S, Soltani MK, Asgary S. Photodynamic therapy in endodontics: a literature review. Photodiagnosis Photodyn Ther. 2013 Sep;10(3):349-54. http://dx.doi.org/10.1016/j.pdpdt.2013.02.003.
- Meire MA, Coenye T. Photodynamic antimicrobial therapy in endodontics: a literature review. Photomed Laser Surg. 2017 Jul;35(7):393-399. http://dx.doi.org/10.1089/pho.2016.4199.
- Souza LC, Brito PR, de Oliveira JC, et al. Photodynamic therapy in endodontic treatment of deciduous teeth: a case series. Photodiagnosis Photodyn Ther. 2015 Dec;12(4):616-9. http://dx.doi.org/10.1016/j.pdpdt.2015.09.006.
- Gunaydin G, Gedik ME, Ayan S. Photodynamic therapy—current limitations and novel approaches. Frontiers in Chemistry. 2021 Jun 10;9:691697.